What should Diabetics know about COVID-19?
COVID-19 is a highly infectious viral infection due to the Novel Coronavirus. The infection originated in Wuhan, China where it spread quickly. There are over 2,258,516 n people infected with the virus around the world and over 154,371 deaths. In India, there are 14,378 confirmed cases and 201 deaths. The virus is a new strain and countries around the world are unsure how to tackle and treat the virus.
The virus spreads via the droplets when an infected person coughs, sneezes, or talks. The virus can survive in the air and on solid surfaces for a few hours or days depending on the type of surface. If you touch a contaminated surface and then touch your nose, mouth, or eyes you can get infected. The virus is killed in the environment when the surface is wiped with an alcohol-based solution.
Most people experience mild to moderate symptoms and make a complete recovery. Symptoms of COVID-19 are:-
Muscle pain and headache
Fever
Dry Cough
Fatigue
Sore throat
Repeated shaking with chills
Loss of smell and taste
More severe symptoms may include:-
Pneumonia
Breathing difficulty
Diarrhea
Chest pain
Death
The World Health Organization has said patients with Type 1 or Type 2 diabetes are at a higher risk of serious infection if they contract the virus. People with diabetes have lower immunity levels. Your immune system protects you from infections. Diabetic patients may have other health problems such as high blood pressure, obesity, and heart disease. This will make you more susceptible to infections. Research showed that 22% of patients hospitalized in China with severe infections had diabetes.
Other than diabetes other high-risk categories are:-
cancer patients
Smokers
Bone marrow transplant or organ transplant patients.
Patients taking immune-suppression medications or steroids.
If you have AIDS or HIV.
Patients with chronic lung disease or you suffer from moderate or severe asthma.
Patients with chronic lung or kidney infections.
If you are over 65.
Your risks are higher if you don’t control your sugar levels. Higher sugar levels lower your immunity levels. Lower immunity levels make fighting the infection tougher. It is important to manage your diabetes more vigilantly in this period. Eat healthy meals, exercise indoors for at least 30 minutes. Exercise will improve your mental health as well. It is extremely important to have your medication on time. It is important to ensure you have insulin or glucose tablets handy. You can order your medicines at home in advance before your supply ends. You can monitor your sugar levels with blood tests at home or using a glucometer. Type 1 diabetic patients can either order urine tests or use urine ketone strips. If you feel your diabetic symptoms are worsening you can consult your doctor through video consultation.
It is extremely important to follow the precautions laid down by the government such as:-
Clean your hands with either soap or sanitizer frequently for at least 20 seconds.
Wear a mask when you are feeling unwell.
Sneeze or cough into tissues that must be disposed of properly.
Practice social distancing.
Clean and disinfect surfaces at home frequently.
Stay indoors as much as possible.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...
Continue Reading
A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...
Continue Reading
Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...
Continue Reading
Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...
Continue Reading
Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...
Continue Reading
Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...
Continue Reading
OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...
Continue Reading
Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...
Continue Reading
A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...
Continue Reading
A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...
Continue Reading
Top 5 Most Recently Viewed Articles
Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...
Continue Reading
Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...
Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...
Continue Reading
Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...
Continue Reading
Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...
Continue Reading